Transcatheter aortic valve implantation (TAVI) and sutureless aortic valve replacement (SU-AVR) are suitable alternatives to conventional surgery. The aim of this study is to compare early outcomes of 2,177 patients treated with TAVI (86.6%) or with SU-AVR (13.4%).

The sutureless aortic valve replacement is associated with better device success and a lower incidence of PVL, compared with TAVI. Nevertheless, patients treated with SU-AVR were more likely to receive a permanent pacemaker. SU-AVR and TAVI provide good results in patients who have severe symptomatic aortic valve stenosis. Given the multiple therapeutic options available, patients may receive the treatment that is most appropriate for their clinical and anatomical characteristics.

Reference

D'Onofrio A, Salizzoni S, Rubino AS, Besola L, Filippini C, Alfieri O, Colombo A, Agrifoglio M, Fischlein T, Rapetto F, Tarantini G, Dalèn M, Gabbieri D, Meuris B, Savini C, Gatti G, Aiello ML, Biancari F, Livi U, Stefàno PL, Cassese M, Borrello B, et al. The rise of new technologies for aortic valve stenosis: A comparison of sutureless and transcatheter aortic valve implantation. J Thorac Cardiovasc Surg. 2016 Jan 11. pii: S0022-5223(15)02347-8. doi: 10.1016/j.jtcvs.2015.11.041. [Epub ahead of print]

Go to full text